Mary (@MaryShapley) profile picture

Dog lover, triathlete, social worker, data nerd. She/her.

Chicago, IL
Joined January 2015
I feel like this is @haroldpollack goal when teaching Econ
My favorite student eval from this past semester: "The class did not have the most thrilling content so I think she did the best that she could" 💀
1
2
466
I have also saved a turtle during a run, so I am basically the same as @des_linden
This is when I stoped to save a turtle. Please send my most compassionate award, thanks. 💁‍♀️
5
The author makes good argument that we can’t stop at insulin in constraining prices of life-saving diabetes drugs. Of course keeping insulin prices high to encourage more-powerful medication use is not the right way to address the challenges he considers. theatlantic.com/health/archi…
1
5
There are better ways to address the author’s @MikeRoseMDMPH concerns than by keeping the price of life saving insulin high. I have diabetes. I also have a good job with good insurance. Still have gone into debt to pay for diabetes care.
Laws that make insulin cheaper for patients are a great idea. But in their current version, they could lead to even more diabetes-related deaths overall, @MikeRoseMDMPH writes. theatlantic.com/health/archi…
1
No. Demand for insulin is price-inelastic. Human bodies need the amount of insulin they need. Biology doesn’t care about prices. …and it’s been a quarter century since there’s been much significant innovation.
13
31
184
Thrilled to have a poster @AcademyHealth with my @UChiUrbanLabs @jcoinctc ROMI colleagues. Now to convince @arrpeeoh to let me hang it up in our house once back home…
1
2
Really bummed that there wasn’t an all inclusive pass to cover both conferences. #ARM22 #academyhealth #AwesomeCon2022
1
3
When the abstract is limited to 200 words.
58
781
100
5,842
As if living with #diabetes wasn’t hard enough…@MetLife denied me for life insurance. My last A1C was 5.1 btw. This was for $10k supplement through spouse job.
2
I helped write a thing!
“Social work is a neglected stepchild of American health policy practice and discourse” write authors @haroldpollack @jd_lerner & Mary Beth Shapley of @UChiUrbanLabs in the latest Milbank Quarterly Opinion. A rebuke to health policy colleagues and peers buff.ly/3lBaBBD
1
Interests of people w/ diabetes can’t truly be served by advocacy orgs who are funded by drug companies. #type1diabetes #type1lookslikeme #Insulin4all
One in two people worldwide who need insulin can’t properly access it. But the two biggest American diabetes nonprofits take millions annually from insulin manufacturers — a conflict of interest that is hurting people with diabetes. jacobinmag.com/2022/04/diabe…
Enjoying a quantity of pizza and insulin to celebrate pi day and a successful site visit with colleagues from @UChiUrbanLabs and @uicpublichealth
1
1
3
I can do this thanks to @GaryScheiner and his amazing “how to bolus for pizza” video.
if you're having a shitty time with your mental health and are low functioning i feel u & sympathise. here's a list of potential actions for u to take to feel better/exist through it. try to pick a few & do them, but if you can't : that's valid too. let's go
291
37,746
2,431
87,878
THIS. Redesivir is an inpatient drug. But people who don’t work in healthcare might not have good understanding of what payment based on DRG means.
I’m confused by this phrasing and people’s concern on Twitter. If this is an inpatient drug, Medicare and Medicaid aren’t paying for it — the hospitals are. So Gilead isn’t “charging” Medicare anything and when the government is the purchaser it is paying the government price.
1
Short version: Medicare pays hospitals a flat rate based on diagnosis. Generally speaking it doesn’t matter how long a patient stays or what treatment they get. Hospitals are the ones paying for the drugs.